Modifiable Risk Factors Associated With Moyamoya Disease
Peicong Ge(Capital Medical University), Jizong Zhao(Capital Medical University), Xiaofeng Deng(Capital Medical University), Xun Ye(Capital Medical University), Rong Wang(Yinchuan First People's Hospital), Dong Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qian Zhang(Brigham and Women's Hospital), Yan Zhang(Shenzhen Children's Hospital), Wang Jia(Capital Medical University), Xingju Liu(Capital Medical University)
Cited by 63
Related Papers
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
|Journal of Clinical Investigation|2013|107
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105
Expression of Concern: Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor‐suppressive miR‐124
|FEBS Letters|2013|90
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance
|Journal of neurosurgery|2016|88